TY - JOUR A1 - Becker, Lore A1 - Kling, Eva A1 - Schiller, Evelyn A1 - Zeh, Ramona A1 - Schrewe, Anja A1 - Hölter, Sabine M. A1 - Mossbrugger, Ilona A1 - Calzada-Wack, Julia A1 - Strecker, Valentina A1 - Wittig, Ilka A1 - Dumitru, Iulia A1 - Wenz, Tina A1 - Bender, Andreas A1 - Aichler, Michaela A1 - Janik, Dirk A1 - Neff, Frauke A1 - Walch, Axel A1 - Quintanilla-Fend, Leticia A1 - Floss, Thomas A1 - Bekeredjian, Raffi A1 - Gailus-Durner, Valérie A1 - Fuchs, Helmut A1 - Wurst, Wolfgang A1 - Meitinger, Thomas A1 - Prokisch, Holger A1 - Hrabé de Angelis, Martin A1 - Klopstock, Thomas T1 - MTO1-deficient mouse model mirrors the human phenotype showing complex I defect and cardiomyopathy T2 - PLoS One N2 - Recently, mutations in the mitochondrial translation optimization factor 1 gene (MTO1) were identified as causative in children with hypertrophic cardiomyopathy, lactic acidosis and respiratory chain defect. Here, we describe an MTO1-deficient mouse model generated by gene trap mutagenesis that mirrors the human phenotype remarkably well. As in patients, the most prominent signs and symptoms were cardiovascular and included bradycardia and cardiomyopathy. In addition, the mutant mice showed a marked worsening of arrhythmias during induction and reversal of anaesthesia. The detailed morphological and biochemical workup of murine hearts indicated that the myocardial damage was due to complex I deficiency and mitochondrial dysfunction. In contrast, neurological examination was largely normal in Mto1-deficient mice. A translational consequence of this mouse model may be to caution against anaesthesia-related cardiac arrhythmias which may be fatal in patients. Y1 - 2014 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/36429 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-364294 SN - 1932-6203 N1 - Copyright: © 2014 Becker et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. VL - 9 IS - (12):e114918 PB - PLoS CY - Lawrence, Kan. ER -